Show simple item record

dc.contributor.authorMcMahon, EJ
dc.contributor.authorCampbell, KL
dc.contributor.authorBauer, JD
dc.contributor.authorMudge, DW
dc.contributor.authorKelly, JT
dc.date.accessioned2021-07-19T06:13:38Z
dc.date.available2021-07-19T06:13:38Z
dc.date.issued2021
dc.identifier.issn1465-1858
dc.identifier.doi10.1002/14651858.CD010070.pub3
dc.identifier.urihttp://hdl.handle.net/10072/406133
dc.description.abstractBackground: Evidence indicates that reducing dietary salt may reduce the incidence of heart disease and delay decline in kidney function in people with chronic kidney disease (CKD). This is an update of a review first published in 2015. Objectives: To evaluate the benefits and harms of altering dietary salt for adults with CKD. Search methods: We searched the Cochrane Kidney and Transplant Register of Studies up to 6 October 2020 through contact with the Information Specialist using search terms relevant to this review. Studies in the Register are identified through searches of CENTRAL, MEDLINE, and EMBASE, conference proceedings, the International Clinical Trials Register (ICTRP) Search Portal and ClinicalTrials.gov. Selection criteria: Randomised controlled trials comparing two or more levels of salt intake in adults with any stage of CKD. Data collection and analysis: Two authors independently assessed studies for eligibility, conducted risk of bias evaluation and evaluated confidence in the evidence using GRADE. Results were summarised using random effects models as risk ratios (RR) for dichotomous outcomes or mean differences (MD) for continuous outcomes, with 95% confidence intervals (CI). Main results: We included 21 studies (1197 randomised participants), 12 in the earlier stages of CKD (779 randomised participants), seven in dialysis (363 randomised participants) and two in post-transplant (55 randomised participants). Selection bias was low in seven studies, high in one and unclear in 13. Performance and detection biases were low in four studies, high in two, and unclear in 15. Attrition and reporting biases were low in 10 studies, high in three and unclear in eight. Because duration of the included studies was too short (1 to 36 weeks) to test the effect of salt restriction on endpoints such as death, cardiovascular events or CKD progression, changes in salt intake on blood pressure and other secondary risk factors were examined. Reducing salt by mean -73.51 mmol/day (95% CI -92.76 to -54.27), equivalent to 4.2 g or 1690 mg sodium/day, reduced systolic/diastolic blood pressure by -6.91/-3.91 mm Hg (95% CI -8.82 to -4.99/-4.80 to -3.02; 19 studies, 1405 participants; high certainty evidence). Albuminuria was reduced by 36% (95% CI 26 to 44) in six studies, five of which were carried out in people in the earlier stages of CKD (MD -0.44, 95% CI -0.58 to -0.30; 501 participants; high certainty evidence). The evidence is very uncertain about the effect of lower salt intake on weight, as the weight change observed (-1.32 kg, 95% CI -1.94 to -0.70; 12 studies, 759 participants) may have been due to fluid volume, lean tissue, or body fat. Lower salt intake may reduce extracellular fluid volume in the earlier stages of CKD (-0.87 L, 95% CI -1.17 to -0.58; 3 studies; 187 participants; low certainty evidence). The evidence is very uncertain about the effect of lower salt intake on reduction in antihypertensive dose (RR 2.45, 95% CI 0.98 to 6.08; 8 studies; 754 participants). Lower salt intake may lead to symptomatic hypotension (RR 6.70, 95% CI 2.40 to 18.69; 6 studies; 678 participants; moderate certainty evidence). Data were sparse for other types of adverse events. Authors' conclusions: We found high certainty evidence that salt reduction reduced blood pressure in people with CKD, and albuminuria in people with earlier stage CKD in the short-term. If such reductions could be maintained long-term, this effect may translate to clinically significant reductions in CKD progression and cardiovascular events. Research into the long-term effects of sodium-restricted diet for people with CKD is warranted.
dc.description.peerreviewedYes
dc.languageEnglish
dc.publisherWiley
dc.relation.ispartofissue6
dc.relation.ispartofjournalCochrane Database of Systematic Reviews
dc.relation.ispartofvolume2021
dc.subject.fieldofresearchCardiovascular medicine and haematology
dc.subject.fieldofresearchImmunology
dc.subject.fieldofresearchcode3201
dc.subject.fieldofresearchcode3204
dc.titleAltered dietary salt intake for people with chronic kidney disease
dc.typeJournal article
dc.type.descriptionC1 - Articles
dcterms.bibliographicCitationMcMahon, EJ; Campbell, KL; Bauer, JD; Mudge, DW; Kelly, JT, Altered dietary salt intake for people with chronic kidney disease, Cochrane Database of Systematic Reviews, 2021, 2021 (6)
dc.date.updated2021-07-18T22:51:19Z
dc.description.versionVersion of Record (VoR)
gro.rights.copyright© 2021 The Cochrane Collaboration. Published by John Wiley & Sons, Ltd. This review is published as a Cochrane Review in the Cochrane Database of Systematic Reviews 2021, 6. Cochrane Reviews are regularly updated as new evidence emerges and in response to comments and criticisms, and the Cochrane Database of Systematic Reviews should be consulted for the most recent version of the Review.
gro.hasfulltextFull Text
gro.griffith.authorKelly, Jaimon
gro.griffith.authorCampbell, Katrina


Files in this item

This item appears in the following Collection(s)

  • Journal articles
    Contains articles published by Griffith authors in scholarly journals.

Show simple item record